Navigation Links
Panelists Announced for Decision Resources Group One-day Biologics and Biosimilars Seminar in San Diego
Date:4/18/2013

BURLINGTON, Mass., April 18, 2013 /PRNewswire/ -- Decision Resources Group is pleased to announce a distinguished lineup of speakers who will be joining its well-regarded Competitive Landscape Seminar Series focusing on Biologics and Biosimilars on May 2, 2013 at the Hotel Solamar in San Diego, CA. The panel discussion will focus on the key issues affecting the success of the biologics and biosimilars market. Panelists will share their thoughts on market access for biosimilars, the role of indication extrapolation and automatic substitution, as well as their perspective on appropriate pricing models for brands and biosimilars as this dynamic market segment continues to evolve.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36768LOGO )

Moderated by Andrew Merron , Ph.D., Senior Director, Biosimilars Research, BioTrends Research Group, panelists include:

  • John L. Fox , M.D., M.H.A., Associate Vice President of Medical Affairs, Priority Health, Michigan
  • Kjel A. Johnson , Senior Vice President, Strategy and Business Development at Magellan Pharmacy Services
  • Atheer A. Kaddis , Pharm.D., Senior Vice President, Sales and Business Development at Diplomat Specialty Pharmacy

Panelists will focus on the key issues affecting the biologics landscape and the emerging biosimilars sector based on the European experience of biosimilars to date and expectations for the U.S. Topics to be discussed will include the anticipated future trends in the biologics market and the challenges and drivers of biosimilar adoption in the U.S.

This Decision Resources Group Competitive Landscape Seminar is a one-day strategic informational event covering key issues in the biologics and biosimilars market and will include presentations from six prominent DRG analysts. The seminar is intended for pharmaceutical professionals involved in market research, business development and competitive intelligence.  Attendees are invited to engage with analysts and peers with a post-event reception.

For more information and to register, please visit:

http://www.competitivelandscapeseries.com/biologics-and-biosimilars

Media Contact:
Media interested in attending the seminar should contact Roy Strunin at rstrunin@dresources.com or 781-993-2515 for additional information.

About the Competitive Landscape Seminar Series

The Competitive Landscape Seminar Series: Biologics and Biosimilars will be held on May 2, 2013. This high-value, one-day seminar has been developed specifically for biopharmaceutical market research executives as well as biologics and biosimilars product teams. Expert analysts from Decision Resources Group companies—Decision Resources and BioTrends Research Group—will share their latest research findings on key biologics and biosimilars trends.

About Decision Resources Group

Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.


 


'/>"/>
SOURCE Decision Resources Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Gen-Probe Withdraws from Previously Announced Investor Presentations
2. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
3. LTCLINK-Tank Competition Announced To Introduce Your Emerging Product to the Aging Care Continuum
4. Delcath Announced Changes To Board Of Directors
5. Speakers Announced for the 2012 International Iridoid Research Symposium
6. Bausch + Lomb Announces Extension of Early Tender Date for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
7. Online Pharmacy Domain Policy Changes Announced by ICANN Registrar Internet.bs Corp.
8. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
9. Results from the Largest Known Cholesterol Survey Conducted in the U.S. Announced at the American Heart Associations Annual Scientific Sessions
10. Hanmi and Kinex Announced Korean FDA Allowance of the KX01 IND Application
11. MEK162 Registration Path Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Company plc (NYSE, TASE: PRGO) today announced it has received ... hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 ... homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per 5 ... adults and children 6 years of age and older. Annual ... $16 million.   ...
(Date:2/17/2017)... Feb. 17, 2017   FormFast , the leader ... new partnership with Engage , one of the ... . FormFast will serve as the forms automation ... with MEDITECH .  FormFast is ... to complement and enhance the electronic health record. FormFast,s ...
(Date:2/16/2017)... Feb. 16, 2017 Absorption Systems, a global ... devices, is pleased to announce that its Chief Operating ... as a winner of the 2017 Executive Management Award. ... and recognizes driven executives for their creative management vision, ... awards ceremony and celebration is on March 8, 2017 ...
Breaking Medicine Technology:
(Date:2/18/2017)... MANDEVILLE, La. (PRWEB) , ... February 18, 2017 ... ... Network released today provides the latest information and contact points to easily connect ... including home care, assisted living, and elder-care funding. It also conveys material on ...
(Date:2/17/2017)... ... February 17, 2017 , ... While EHR data ... has introduced an innovative workstation designed to reduce nursing fatigue while enhancing productivity. ... EHR Workstation offers a lightweight, highly mobile, multi-functional alternative to the limitations of ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network ... prescribing of controlled and non-controlled substances plus the ability to manage orders on ... United States now accept electronic prescriptions, according to the Office of the National ...
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... February 17, ... ... Devices, Implementing the Steps to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. ... , Do manufacturers distinguish between corrective action (CA) and preventive action ...
Breaking Medicine News(10 mins):